rs17110944

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002609.4(PDGFRB):​c.85A>T​(p.Ile29Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0179 in 1,547,842 control chromosomes in the GnomAD database, including 2,111 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.068 ( 1000 hom., cov: 33)
Exomes 𝑓: 0.012 ( 1111 hom. )

Consequence

PDGFRB
NM_002609.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.173
Variant links:
Genes affected
PDGFRB (HGNC:8804): (platelet derived growth factor receptor beta) The protein encoded by this gene is a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer (PDGFB or PDGFD) or a heterodimer (PDGFA and PDGFB). This gene is essential for normal development of the cardiovascular system and aids in rearrangement of the actin cytoskeleton. This gene is flanked on chromosome 5 by the genes for granulocyte-macrophage colony-stimulating factor and macrophage-colony stimulating factor receptor; all three genes may be implicated in the 5-q syndrome. A translocation between chromosomes 5 and 12, that fuses this gene to that of the ETV6 gene, results in chronic myeloproliferative disorder with eosinophilia. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0034821332).
BP6
Variant 5-150135834-T-A is Benign according to our data. Variant chr5-150135834-T-A is described in ClinVar as [Benign]. Clinvar id is 258780.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-150135834-T-A is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.206 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PDGFRBNM_002609.4 linkc.85A>T p.Ile29Phe missense_variant Exon 3 of 23 ENST00000261799.9 NP_002600.1 P09619-1Q59F04
PDGFRBNM_001355016.2 linkc.-108A>T 5_prime_UTR_variant Exon 2 of 22 NP_001341945.1
PDGFRBNM_001355017.2 linkc.-433A>T 5_prime_UTR_variant Exon 3 of 23 NP_001341946.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PDGFRBENST00000261799.9 linkc.85A>T p.Ile29Phe missense_variant Exon 3 of 23 1 NM_002609.4 ENSP00000261799.4 P09619-1
PDGFRBENST00000520579.5 linkn.85A>T non_coding_transcript_exon_variant Exon 3 of 23 1 ENSP00000430026.1 E5RH16
PDGFRBENST00000517957.1 linkc.85A>T p.Ile29Phe missense_variant Exon 3 of 4 4 ENSP00000430715.1 E5RII0
PDGFRBENST00000517488.1 linkc.-108A>T 5_prime_UTR_variant Exon 2 of 3 3 ENSP00000429218.1 E5RJ14

Frequencies

GnomAD3 genomes
AF:
0.0680
AC:
10334
AN:
152020
Hom.:
990
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.210
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0558
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0362
Gnomad SAS
AF:
0.0606
Gnomad FIN
AF:
0.0143
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00137
Gnomad OTH
AF:
0.0402
GnomAD3 exomes
AF:
0.0381
AC:
7455
AN:
195908
Hom.:
540
AF XY:
0.0315
AC XY:
3281
AN XY:
104086
show subpopulations
Gnomad AFR exome
AF:
0.213
Gnomad AMR exome
AF:
0.0880
Gnomad ASJ exome
AF:
0.000199
Gnomad EAS exome
AF:
0.0316
Gnomad SAS exome
AF:
0.0530
Gnomad FIN exome
AF:
0.0156
Gnomad NFE exome
AF:
0.00127
Gnomad OTH exome
AF:
0.0219
GnomAD4 exome
AF:
0.0124
AC:
17254
AN:
1395704
Hom.:
1111
Cov.:
32
AF XY:
0.0125
AC XY:
8603
AN XY:
687500
show subpopulations
Gnomad4 AFR exome
AF:
0.215
Gnomad4 AMR exome
AF:
0.0837
Gnomad4 ASJ exome
AF:
0.0000922
Gnomad4 EAS exome
AF:
0.0246
Gnomad4 SAS exome
AF:
0.0501
Gnomad4 FIN exome
AF:
0.0155
Gnomad4 NFE exome
AF:
0.000697
Gnomad4 OTH exome
AF:
0.0233
GnomAD4 genome
AF:
0.0682
AC:
10383
AN:
152138
Hom.:
1000
Cov.:
33
AF XY:
0.0671
AC XY:
4990
AN XY:
74380
show subpopulations
Gnomad4 AFR
AF:
0.210
Gnomad4 AMR
AF:
0.0561
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.0363
Gnomad4 SAS
AF:
0.0600
Gnomad4 FIN
AF:
0.0143
Gnomad4 NFE
AF:
0.00137
Gnomad4 OTH
AF:
0.0431
Alfa
AF:
0.0295
Hom.:
85
Bravo
AF:
0.0770
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.212
AC:
933
ESP6500EA
AF:
0.000814
AC:
7
ExAC
AF:
0.0377
AC:
4561
Asia WGS
AF:
0.0750
AC:
260
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Mar 20, 2019
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

PDGFRB-related disorder Benign:1
Jun 08, 2022
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Myofibromatosis, infantile, 1 Benign:1
Feb 01, 2025
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Myeloproliferative disorder, chronic, with eosinophilia Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Infantile myofibromatosis;C1866182:Acroosteolysis-keloid-like lesions-premature aging syndrome;C3554321:Basal ganglia calcification, idiopathic, 4;C4225270:Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.41
CADD
Benign
0.66
DANN
Benign
0.73
DEOGEN2
Benign
0.26
T;T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.092
N
LIST_S2
Benign
0.52
T;T
MetaRNN
Benign
0.0035
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.34
N;.
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-0.81
N;N
REVEL
Benign
0.019
Sift
Benign
0.33
T;T
Sift4G
Benign
0.42
T;.
Polyphen
0.022
B;.
Vest4
0.059
MPC
0.36
ClinPred
0.00030
T
GERP RS
-1.5
Varity_R
0.060
gMVP
0.29

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs17110944; hg19: chr5-149515397; COSMIC: COSV55802660; COSMIC: COSV55802660; API